Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_assertion type Assertion NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_head.
- NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_assertion description "[A total of 145 adult patients diagnosed with genotype 1 chronic hepatitis C (CHC) who had completed a 48-wk regimen of pegylated-interferon ?-2a or -2b plus ribavirin combination therapy were recruited from six large urban healthcare centers and 199 healthy blood donors (controls) from a single site between January 2010 and January 2012.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_provenance.
- NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_assertion evidence source_evidence_literature NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_provenance.
- NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_assertion SIO_000772 24259970 NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_provenance.
- NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_assertion wasDerivedFrom befree-2016 NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_provenance.
- NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_assertion wasGeneratedBy ECO_0000203 NP1130103.RATsDZraINma9fsEqF8hd2dmnaOR_XWcznnAeCyuQ46xg130_provenance.